Uluer AZ - Search Results

1

Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin.

Wood GS, Crooks CF, Uluer AZ. Wood GS, et al. Among authors: uluer az. J Invest Dermatol. 1995 Jul;105(1):51-5. doi: 10.1111/1523-1747.ep12312548. J Invest Dermatol. 1995. PMID: 7615976 Free article.

2

Polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE): sensitivity, band pattern analysis, and methodologic optimization.

Wood GS, Uluer AZ. Wood GS, et al. Among authors: uluer az. Am J Dermatopathol. 1999 Dec;21(6):547-51. doi: 10.1097/00000372-199912000-00008. Am J Dermatopathol. 1999. PMID: 10608248

3

Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.

Choudhary MS, Sachs N, Uluer A, Glennon RA, Westkaemper RB, Roth BL. Choudhary MS, et al. Mol Pharmacol. 1995 Mar;47(3):450-7. Mol Pharmacol. 1995. PMID: 7700242

4

5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.

Roth BL, Palvimaki EP, Berry S, Khan N, Sachs N, Uluer A, Choudhary MS. Roth BL, et al. J Pharmacol Exp Ther. 1995 Dec;275(3):1638-46. J Pharmacol Exp Ther. 1995. PMID: 8531139

5

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR. Roth BL, et al. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. J Pharmacol Exp Ther. 1994. PMID: 7908055

6

High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.

Roth BL, Choudhary MS, Khan N, Uluer AZ. Roth BL, et al. Among authors: uluer az. J Pharmacol Exp Ther. 1997 Feb;280(2):576-83. J Pharmacol Exp Ther. 1997. PMID: 9023266

7

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.

Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.

8

Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation.

Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D. Gelfond D, et al. Clin Transl Gastroenterol. 2017 Mar 16;8(3):e81. doi: 10.1038/ctg.2017.10. Clin Transl Gastroenterol. 2017. PMID: 28300821 Free PMC article.

9

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis.

Elborn JS, Konstan MW, Taylor-Cousar JL, Fajac I, Horsley A, Sutharsan S, Aaron SD, Daines CL, Uluer A, Downey DG, Lucidi VV, Ahuja S, Springman E, Mershon J, Grosswald R, Rowe SM; EMPIRE-CF study group. Elborn JS, et al. J Cyst Fibros. 2021 Nov;20(6):1026-1034. doi: 10.1016/j.jcf.2021.08.007. Epub 2021 Sep 17. J Cyst Fibros. 2021. PMID: 34538755 Free PMC article. Clinical Trial.

10

Family-building and parenting considerations for people with cystic fibrosis.

Kazmerski TM, West NE, Jain R, Uluer A, Georgiopoulos AM, Aitken ML, Taylor-Cousar JL. Kazmerski TM, et al. Pediatr Pulmonol. 2022 Feb;57 Suppl 1(Suppl 1):S75-S88. doi: 10.1002/ppul.25620. Epub 2021 Aug 18. Pediatr Pulmonol. 2022. PMID: 34407321 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters